Copyright Reports & Markets. All rights reserved.

Global Congenital Heart Disease Treatment Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Congenital Heart Disease Treatment Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Medication
      • 1.4.3 Surgical Therapy
    • 1.5 Market by Application
      • 1.5.1 Global Congenital Heart Disease Treatment Market Share by Application (2014-2025)
      • 1.5.2 Hospitals and Clinics
      • 1.5.3 Diagnostic Centers
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Congenital Heart Disease Treatment Market Size
    • 2.2 Congenital Heart Disease Treatment Growth Trends by Regions
      • 2.2.1 Congenital Heart Disease Treatment Market Size by Regions (2014-2025)
      • 2.2.2 Congenital Heart Disease Treatment Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Congenital Heart Disease Treatment Market Size by by Players
      • 3.1.1 Global Congenital Heart Disease Treatment Revenue by by Players (2014-2019)
      • 3.1.2 Global Congenital Heart Disease Treatment Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Congenital Heart Disease Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.2 Congenital Heart Disease Treatment Key Players Head office and Area Served
    • 3.3 Key Players Congenital Heart Disease Treatment Product/Solution/Service
    • 3.4 Date of Enter into Congenital Heart Disease Treatment Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Congenital Heart Disease Treatment Market Size by Type (2014-2019)
    • 4.2 Global Congenital Heart Disease Treatment Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Congenital Heart Disease Treatment Market Size (2014-2019)
    • 5.2 Congenital Heart Disease Treatment Key Players in United States
    • 5.3 United States Congenital Heart Disease Treatment Market Size by Type
    • 5.4 United States Congenital Heart Disease Treatment Market Size by Application

    6 Europe

    • 6.1 Europe Congenital Heart Disease Treatment Market Size (2014-2019)
    • 6.2 Congenital Heart Disease Treatment Key Players in Europe
    • 6.3 Europe Congenital Heart Disease Treatment Market Size by Type
    • 6.4 Europe Congenital Heart Disease Treatment Market Size by Application

    7 China

    • 7.1 China Congenital Heart Disease Treatment Market Size (2014-2019)
    • 7.2 Congenital Heart Disease Treatment Key Players in China
    • 7.3 China Congenital Heart Disease Treatment Market Size by Type
    • 7.4 China Congenital Heart Disease Treatment Market Size by Application

    8 Japan

    • 8.1 Japan Congenital Heart Disease Treatment Market Size (2014-2019)
    • 8.2 Congenital Heart Disease Treatment Key Players in Japan
    • 8.3 Japan Congenital Heart Disease Treatment Market Size by Type
    • 8.4 Japan Congenital Heart Disease Treatment Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Congenital Heart Disease Treatment Market Size (2014-2019)
    • 9.2 Congenital Heart Disease Treatment Key Players in Southeast Asia
    • 9.3 Southeast Asia Congenital Heart Disease Treatment Market Size by Type
    • 9.4 Southeast Asia Congenital Heart Disease Treatment Market Size by Application

    10 India

    • 10.1 India Congenital Heart Disease Treatment Market Size (2014-2019)
    • 10.2 Congenital Heart Disease Treatment Key Players in India
    • 10.3 India Congenital Heart Disease Treatment Market Size by Type
    • 10.4 India Congenital Heart Disease Treatment Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Congenital Heart Disease Treatment Market Size (2014-2019)
    • 11.2 Congenital Heart Disease Treatment Key Players in Central & South America
    • 11.3 Central & South America Congenital Heart Disease Treatment Market Size by Type
    • 11.4 Central & South America Congenital Heart Disease Treatment Market Size by Application

    12 International Players Profiles

    • 12.1 Pfizer
      • 12.1.1 Pfizer Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Congenital Heart Disease Treatment Introduction
      • 12.1.4 Pfizer Revenue in Congenital Heart Disease Treatment Business (2014-2019)
      • 12.1.5 Pfizer Recent Development
    • 12.2 Novartis
      • 12.2.1 Novartis Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Congenital Heart Disease Treatment Introduction
      • 12.2.4 Novartis Revenue in Congenital Heart Disease Treatment Business (2014-2019)
      • 12.2.5 Novartis Recent Development
    • 12.3 Abbott Laboratories
      • 12.3.1 Abbott Laboratories Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Congenital Heart Disease Treatment Introduction
      • 12.3.4 Abbott Laboratories Revenue in Congenital Heart Disease Treatment Business (2014-2019)
      • 12.3.5 Abbott Laboratories Recent Development
    • 12.4 Roche
      • 12.4.1 Roche Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Congenital Heart Disease Treatment Introduction
      • 12.4.4 Roche Revenue in Congenital Heart Disease Treatment Business (2014-2019)
      • 12.4.5 Roche Recent Development
    • 12.5 GSK
      • 12.5.1 GSK Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Congenital Heart Disease Treatment Introduction
      • 12.5.4 GSK Revenue in Congenital Heart Disease Treatment Business (2014-2019)
      • 12.5.5 GSK Recent Development
    • 12.6 Sanofi
      • 12.6.1 Sanofi Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Congenital Heart Disease Treatment Introduction
      • 12.6.4 Sanofi Revenue in Congenital Heart Disease Treatment Business (2014-2019)
      • 12.6.5 Sanofi Recent Development
    • 12.7 Johnson & Johnson
      • 12.7.1 Johnson & Johnson Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Congenital Heart Disease Treatment Introduction
      • 12.7.4 Johnson & Johnson Revenue in Congenital Heart Disease Treatment Business (2014-2019)
      • 12.7.5 Johnson & Johnson Recent Development
    • 12.8 Medtronic
      • 12.8.1 Medtronic Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Congenital Heart Disease Treatment Introduction
      • 12.8.4 Medtronic Revenue in Congenital Heart Disease Treatment Business (2014-2019)
      • 12.8.5 Medtronic Recent Development
    • 12.9 BD
      • 12.9.1 BD Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Congenital Heart Disease Treatment Introduction
      • 12.9.4 BD Revenue in Congenital Heart Disease Treatment Business (2014-2019)
      • 12.9.5 BD Recent Development
    • 12.10 Boston Scientific
      • 12.10.1 Boston Scientific Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Congenital Heart Disease Treatment Introduction
      • 12.10.4 Boston Scientific Revenue in Congenital Heart Disease Treatment Business (2014-2019)
      • 12.10.5 Boston Scientific Recent Development
    • 12.11 Merck
    • 12.12 Eli Lilly
    • 12.13 Mylan
    • 12.14 Sun Pharmaceutical
    • 12.15 AstraZeneca

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      A congenital heart defect (CHD), also known as a congenital heart anomaly or congenital heart disease, is a problem in the structure of the heart that is present at birth. Signs and symptoms depend on the specific type of problem. Symptoms can vary from none to life-threatening. When present they may include rapid breathing, bluish skin, poor weight gain, and feeling tired. It does not cause chest pain. Most congenital heart problems do not occur with other diseases. Complications that can result from heart defects include heart failure.
      In 2018, the global Congenital Heart Disease Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Congenital Heart Disease Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Congenital Heart Disease Treatment development in United States, Europe and China.

      The key players covered in this study
      Pfizer
      Novartis
      Abbott Laboratories
      Roche
      GSK
      Sanofi
      Johnson & Johnson
      Medtronic
      BD
      Boston Scientific
      Merck
      Eli Lilly
      Mylan
      Sun Pharmaceutical
      AstraZeneca

      Market segment by Type, the product can be split into
      Medication
      Surgical Therapy

      Market segment by Application, split into
      Hospitals and Clinics
      Diagnostic Centers

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Congenital Heart Disease Treatment status, future forecast, growth opportunity, key market and key players.
      To present the Congenital Heart Disease Treatment development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Congenital Heart Disease Treatment are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now